AU7852687A - Glycosaminoglycan derivatives and their use as inhibitors of tumor invasiveness or metastatic profusion - Google Patents
Glycosaminoglycan derivatives and their use as inhibitors of tumor invasiveness or metastatic profusionInfo
- Publication number
- AU7852687A AU7852687A AU78526/87A AU7852687A AU7852687A AU 7852687 A AU7852687 A AU 7852687A AU 78526/87 A AU78526/87 A AU 78526/87A AU 7852687 A AU7852687 A AU 7852687A AU 7852687 A AU7852687 A AU 7852687A
- Authority
- AU
- Australia
- Prior art keywords
- profusion
- metastatic
- inhibitors
- tumor invasiveness
- glycosaminoglycan derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89951186A | 1986-08-21 | 1986-08-21 | |
US899511 | 1986-08-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7852687A true AU7852687A (en) | 1988-03-08 |
Family
ID=25411107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU78526/87A Abandoned AU7852687A (en) | 1986-08-21 | 1987-08-18 | Glycosaminoglycan derivatives and their use as inhibitors of tumor invasiveness or metastatic profusion |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU7852687A (en) |
WO (1) | WO1988001280A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU637143B2 (en) * | 1989-10-04 | 1993-05-20 | N.V. Organon | Sulphated glycosaminoglycuronan with antithrombotic activity |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5262403A (en) * | 1986-03-10 | 1993-11-16 | Board Of Regents, The University Of Texas System | Glycosaminoglycan derivatives and their use as inhibitors of tumor invasiveness of metastatic profusion-II |
AR245455A1 (en) * | 1989-08-18 | 1994-01-31 | Ajorca Sa | Procedure for obtaining heparin, partially or totally n-acetylated in the glucosaminic remains, and products thus obtained, excluding pharmaceutical use. |
AU6872691A (en) * | 1989-10-27 | 1991-05-31 | Case Western Reserve University | Inhibition of cell growth by keratan sulfate, chondroitin sulfate, dermatan sulfate and other glycans |
DE69331633T2 (en) * | 1992-07-24 | 2002-10-31 | Thomas P. Kennedy | MEDICINAL PRODUCTS FOR INHIBITING NEUTROPHILIC ELASTASE AND CATHEPSIN G |
IT1284143B1 (en) * | 1996-09-06 | 1998-05-08 | Istituto Scient Di Chimica E B | SEMI-SYNTHETIC HEPARANSULPHATES WITH HIGH ANTIMETASTIC ACTIVITY AND REDUCED HEMORRAGIC RISK |
US6177545B1 (en) * | 1997-09-02 | 2001-01-23 | Insight Strategy & Marketing Ltd. | Heparanase specific molecular probes and their use in research and medical applications |
AU2878600A (en) | 1999-03-01 | 2000-09-21 | Hadasit Medical Research Services & Development Company Ltd | Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells |
US7781416B2 (en) | 2000-01-25 | 2010-08-24 | Sigma-Tau Research Switzerland S.A. | Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
IT1316986B1 (en) | 2000-01-25 | 2003-05-26 | Sigma Tau Ind Farmaceuti | GLYCOSAMINOGLICAN DERIVATIVES PARTIALLY DESULPHATED NONANTICOAGULANTS WITH ANTIANGIOGENIC ACTIVITY. |
US7879824B2 (en) | 2001-07-31 | 2011-02-01 | Dermal Research Laboratories, Inc. | Methods of preventing or treating diseases and conditions using complex carbohydrates |
CA2417867C (en) * | 2000-07-31 | 2012-09-11 | Dermal Research Laboratories, Inc. | Methods of preventing or treating diseases and conditions using complex carbohydrates |
KR100855331B1 (en) * | 2001-09-12 | 2008-09-04 | 시그마타우 리서치 스위츠랜드 에스.에이 | Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
US7538096B2 (en) | 2004-03-16 | 2009-05-26 | The General Hospital Corporation | Treatment and prevention of abnormal cellular proliferation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2553287B1 (en) * | 1983-10-18 | 1986-09-12 | Choay Sa | COMPOSITIONS BASED ON MUCOPOLYSACCHARIDES OR OLIGOSACCHARIDES, ESPECIALLY BASED ON HEPARIN FRACTIONS OR FRAGMENTS, SUITABLE FOR THE TREATMENT OF CELL PROLIFERATION DISORDERS |
JPS6117A (en) * | 1984-06-11 | 1986-01-06 | Seikagaku Kogyo Co Ltd | Mucopolysaccharide-type cancer-metastatis suppressing agent |
-
1987
- 1987-08-18 AU AU78526/87A patent/AU7852687A/en not_active Abandoned
- 1987-08-18 WO PCT/US1987/002035 patent/WO1988001280A1/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU637143B2 (en) * | 1989-10-04 | 1993-05-20 | N.V. Organon | Sulphated glycosaminoglycuronan with antithrombotic activity |
Also Published As
Publication number | Publication date |
---|---|
WO1988001280A1 (en) | 1988-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU8306791A (en) | Glycosaminoglycan derivatives and their use as inhibitors of tumor invasiveness or metastatic profusion-ii | |
AU587200B2 (en) | Treatment of cancer with phlorizin and its derivatives | |
ZA898141B (en) | Inhibitors of lysyl oxidase | |
AU6800987A (en) | Hyperthermic treatment of tumors | |
PH23495A (en) | Phenoxyalkylaminopyrimidine derivatives and the composition and method of use thereof | |
EP0234854A3 (en) | Preparations for stimulation of tear secrtetion with phosphodiesterase inhibitors and cyclic nucleotideanalogues | |
AU7852687A (en) | Glycosaminoglycan derivatives and their use as inhibitors of tumor invasiveness or metastatic profusion | |
ZA891456B (en) | Derivatives of soluble t-4 | |
GB8611396D0 (en) | Determination of thermophysical properties | |
EP0217419A3 (en) | Reduction of dysfunction in angioplasty procedures | |
AU5730286A (en) | Treatment of factor viii inhibitors | |
PH21839A (en) | Imidazo derivatives and their method of use | |
NZ218856A (en) | Aminoglycosides of 3,21-dihydroxy-14,21-epoxy-24-nor-cholanic acid and derivatives | |
AU5641886A (en) | 5-Pyrimidinecarboxamides and treatment of leukemia and tumors therewith | |
AU576717B2 (en) | N6 - bicycloadenosines and methods of use | |
GB8628049D0 (en) | Use of tetrahydrobenzothienylurea derivatives | |
GB2171205B (en) | Data logging arrangements and methods of obtaining data | |
GB8609125D0 (en) | Determination of nitrite | |
AU4904585A (en) | 13 - acyloxy - 5 - ketomilbemycin derivatives and preparation of 13 - hydroxy - 5 - ketomilbemycin derivatives | |
DE3565101D1 (en) | Ethynylphenoxy and ethynylthiophenoxy derivatives of diphenylhexafluoropropane | |
GB8715317D0 (en) | Treatment of medium | |
PH22427A (en) | Eburnamenine derivatives and method of use thereof | |
AU4348585A (en) | Thermal treatment of phosphate rock | |
IL83193A0 (en) | Cephalosporins and derivatives | |
AU5417886A (en) | Derivatives of 5-fluorouracil |